219660-71-6,MFCD15526725
Catalog No.:AA00BH4B

219660-71-6 | 5-bromo-3-(phthalimidomethyl)pyridine

This product is typically in stock,please click "Inquire" below or
contact us at [email protected] for pricing and availability information.
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00BH4B
Chemical Name:
5-bromo-3-(phthalimidomethyl)pyridine
CAS Number:
219660-71-6
Molecular Formula:
C14H9BrN2O2
Molecular Weight:
317.1375
MDL Number:
MFCD15526725
SMILES:
C1=CC=C2C(=C1)C(=O)N(C2=O)CC3=CC(=CN=C3)Br
Properties

Downstream Synthesis Route

[1]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-US2013/267495,2013,A1Locationinpatent:Paragraph0457

[2]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-US2013/296302,2013,A1Locationinpatent:Paragraph0551

[3]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-US2014/194441,2014,A1Locationinpatent:Paragraph0428

[4]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-US2016/68548,2016,A1Locationinpatent:Paragraph0831CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-US2016/68551,2016,A1Locationinpatent:Paragraph0831

[5]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-US2016/68550,2016,A1Locationinpatent:Paragraph1097

[6]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2016/40193,2016,A1Locationinpatent:Paragraph0744

[7]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23989,2017,A1Locationinpatent:Paragraph0640;0643

[8]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23975,2017,A1Locationinpatent:Paragraph0644;0647

[9]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23993,2017,A1Locationinpatent:Paragraph0649;0652

[10]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/24021,2017,A1Locationinpatent:Paragraph0663;0666

[11]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23987,2017,A1Locationinpatent:Paragraph0644;0647

[12]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23972,2017,A1Locationinpatent:Paragraph0640;0643

[13]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/24013,2017,A1Locationinpatent:Paragraph0663;0666

[14]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/24004,2017,A1Locationinpatent:Paragraph0647

[15]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/24025,2017,A1Locationinpatent:Paragraph0647

[16]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/24003,2017,A1Locationinpatent:Paragraph0644;0647

[17]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/24010,2017,A1Locationinpatent:Paragraph047;050

[18]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23981,2017,A1Locationinpatent:Paragraph0644;0647

[19]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23986,2017,A1Locationinpatent:Paragraph0667;0670

[20]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/24015,2017,A1Locationinpatent:Paragraph042

[21]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23984,2017,A1Locationinpatent:Paragraph0646

[22]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23973,2017,A1Locationinpatent:Paragraph0668

[23]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23980,2017,A1Locationinpatent:Paragraph0647

[24]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23988,2017,A1Locationinpatent:Paragraph0643

[25]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23996,2017,A1Locationinpatent:Paragraph0647

[26]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/24026,2017,A1Locationinpatent:Paragraph0648;0651

[27]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-US2016/75701,2016,A1Locationinpatent:Paragraph0852;0855

[28]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-US2016/68547,2016,A1Locationinpatent:Paragraph0830;0833

[29]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-US2016/68529,2016,A1Locationinpatent:Page/Pagecolumn0834

[30]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-US2016/90380,2016,A1Locationinpatent:Paragraph0855

[31]Bhatti,BalwinderS.;Strachan,Jon-Paul;Breining,ScottR.;Miller,CraigH.;Tahiri,Persida;Crooks,PeterA.;Deo,Niranjan;Day,CynthiaS.;Caldwell,WilliamS.[JournalofOrganicChemistry,2008,vol.73,#9,p.3497-3507]

[32]CurrentPatentAssignee:PHILIPMORRISINTERNATIONALINC.-WO2021/260029,2021,A1Locationinpatent:Page/Pagecolumn55;71-72;73-74

[33]CurrentPatentAssignee:PHILIPMORRISINTERNATIONALINC.-WO2021/260029,2021,A1Locationinpatent:Page/Pagecolumn55;71-72;73-74

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 219660-71-6
Building Blocks
More >
Tags:219660-71-6 Molecular Formula|219660-71-6 MDL|219660-71-6 SMILES|219660-71-6 5-bromo-3-(phthalimidomethyl)pyridine
Catalog No.: AA00BH4B
219660-71-6,MFCD15526725
219660-71-6 | 5-bromo-3-(phthalimidomethyl)pyridine
This product is typically in stock,please click "Inquire" below or contact us at [email protected]for pricing and availability information.
Inquire
Technical Information
Catalog Number: AA00BH4B
Chemical Name: 5-bromo-3-(phthalimidomethyl)pyridine
CAS Number: 219660-71-6
Molecular Formula: C14H9BrN2O2
Molecular Weight: 317.1375
MDL Number: MFCD15526725
SMILES: C1=CC=C2C(=C1)C(=O)N(C2=O)CC3=CC(=CN=C3)Br
Properties
Downstream Synthesis Route
219660-71-6    135124-70-8 

[1]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-US2013/267495,2013,A1Locationinpatent:Paragraph0457

[2]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-US2013/296302,2013,A1Locationinpatent:Paragraph0551

[3]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-US2014/194441,2014,A1Locationinpatent:Paragraph0428

[4]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-US2016/68548,2016,A1Locationinpatent:Paragraph0831CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-US2016/68551,2016,A1Locationinpatent:Paragraph0831

[5]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-US2016/68550,2016,A1Locationinpatent:Paragraph1097

[6]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2016/40193,2016,A1Locationinpatent:Paragraph0744

[7]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23989,2017,A1Locationinpatent:Paragraph0640;0643

[8]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23975,2017,A1Locationinpatent:Paragraph0644;0647

[9]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23993,2017,A1Locationinpatent:Paragraph0649;0652

[10]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/24021,2017,A1Locationinpatent:Paragraph0663;0666

[11]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23987,2017,A1Locationinpatent:Paragraph0644;0647

[12]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23972,2017,A1Locationinpatent:Paragraph0640;0643

[13]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/24013,2017,A1Locationinpatent:Paragraph0663;0666

[14]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/24004,2017,A1Locationinpatent:Paragraph0647

[15]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/24025,2017,A1Locationinpatent:Paragraph0647

[16]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/24003,2017,A1Locationinpatent:Paragraph0644;0647

[17]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/24010,2017,A1Locationinpatent:Paragraph047;050

[18]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23981,2017,A1Locationinpatent:Paragraph0644;0647

[19]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23986,2017,A1Locationinpatent:Paragraph0667;0670

[20]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/24015,2017,A1Locationinpatent:Paragraph042

[21]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23984,2017,A1Locationinpatent:Paragraph0646

[22]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23973,2017,A1Locationinpatent:Paragraph0668

[23]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23980,2017,A1Locationinpatent:Paragraph0647

[24]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23988,2017,A1Locationinpatent:Paragraph0643

[25]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23996,2017,A1Locationinpatent:Paragraph0647

[26]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/24026,2017,A1Locationinpatent:Paragraph0648;0651

[27]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-US2016/75701,2016,A1Locationinpatent:Paragraph0852;0855

[28]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-US2016/68547,2016,A1Locationinpatent:Paragraph0830;0833

[29]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-US2016/68529,2016,A1Locationinpatent:Page/Pagecolumn0834

[30]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-US2016/90380,2016,A1Locationinpatent:Paragraph0855

[31]Bhatti,BalwinderS.;Strachan,Jon-Paul;Breining,ScottR.;Miller,CraigH.;Tahiri,Persida;Crooks,PeterA.;Deo,Niranjan;Day,CynthiaS.;Caldwell,WilliamS.[JournalofOrganicChemistry,2008,vol.73,#9,p.3497-3507]

[32]CurrentPatentAssignee:PHILIPMORRISINTERNATIONALINC.-WO2021/260029,2021,A1Locationinpatent:Page/Pagecolumn55;71-72;73-74

[33]CurrentPatentAssignee:PHILIPMORRISINTERNATIONALINC.-WO2021/260029,2021,A1Locationinpatent:Page/Pagecolumn55;71-72;73-74

Building Blocks More >
Submit
© 2017 AA BLOCKS, INC. All rights reserved.